InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Gordon Christopher R. Officer active across 1 company, notably Cerevel Therapeutics Holdings, Inc.. Aggregated, 4 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €118.4m. History available since 16 October 2023. The latest transaction was filed on 16 October 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Gordon Christopher R is a declarant linked to Cerevel Therapeutics Holdings, Inc., where he is a Director. The 4 filings tracked in the recent sample run from 2023-06-09 to 2024-08-05, with EUR 118434987 of buys and EUR 0 of sells, and the modal transaction nature is Attribution.